Epigenetic study for new head and neck cancer treatments
Part of Cancer clinical trials.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with head and neck squamous cell carcinoma (a common type of head and neck cancer).
- Your tumor has not been treated with any therapy yet (no prior radiotherapy, chemotherapy, or immunotherapy for head and neck cancer).
- Your tumor is in the mouth, voice box, or throat.
- You are able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic information in your tumor to find new ways to treat head and neck cancer. You'll get extra biopsies and blood tests, and your genetic data will be shared with researchers to help personalize future treatments.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study compares gene patterns in tumor tissue and blood samples from patients with HPV-negative head and neck cancer. Understanding these patterns may help doctors better understand the disease and develop better treatments.
This study looks at tumor samples from people with head and neck cancer to understand why some treatments stop working. By studying the tumor tissue, researchers hope to find better ways to treat this cancer in the future.
This study looks at tissue samples from patients who had surgery for head and neck or breast cancer. Researchers want to understand how certain immune cells in the tumor might affect the cancer, which could help improve treatments in the future.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.